ClouDr Group Limited (HKG:9955)
Hong Kong · Delayed Price · Currency is HKD 0.7000
+0.0100 (1.45%)
At close: Mar 27, 2026
ClouDr Group Revenue
In the year 2025, ClouDr Group had annual revenue of 1.62B CNY, down -53.47%. ClouDr Group had revenue of 892.58M in the half year ending June 30, 2025, a decrease of -50.48%.
Revenue
1.62B CNY
Revenue Growth
-53.47%
P/S Ratio
0.25
Revenue / Employee
1.68M CNY
Employees
966
Market Cap
452.00M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.62B | -1.86B | -53.47% |
| Dec 31, 2024 | 3.49B | -202.44M | -5.49% |
| Dec 31, 2023 | 3.69B | 702.48M | 23.51% |
| Dec 31, 2022 | 2.99B | 1.23B | 70.09% |
| Dec 31, 2021 | 1.76B | 917.61M | 109.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 626.85B |
| Charmacy Pharmaceutical | 4.88B |
| Sipai Health Technology | 3.75B |
| ETHK Labs | 3.14B |
| Sinco Pharmaceuticals Holdings | 2.32B |
| 160 Health International | 725.41M |
| Ziyuanyuan Holdings Group | 575.61M |
| Wanjia Group Holdings | 163.70M |